Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
M.JonesD
insightsoftware teamed up with CFO Research to survey 157 senior finance executives regarding technology-enabled risk management initiatives, and how to get there
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
Am J Med Sci
In December 2025, this breakthrough technology expanded to weight management when the FDA approved the Wegovy pill the first oral GLP-1 medication specifically for obesity and weight loss
Some supplements have demonstrated the potential to improve fertility outcomes
US$ 28.13
US$ 26.87
US$ 28.50
US$ 24.48
